IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 3,005.00
-25.00 (-0.83%)
Sep 1, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 42.47 billion as of September 1, 2026. Its market cap has decreased by -62.68% in one year.
Market Cap
42.47B
Enterprise Value
23.51B
Revenue
5.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,005.00
ChartMarket Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 42.47B, a decrease of -91.57%. That is a compound annual growth rate of -64.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 42.47B | -69.36% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genexine | 124.39B |
| MedPacto | 93.91B |
| Vaxcell-Bio Therapeutics | 93.03B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 77.28B |
| Amicogen | 68.34B |
| ENCell | 66.51B |
| ORIENT BIO | 52.11B |